NASDAQ:FBIOP Fortress Biotech (FBIOP) Stock Price, News & Analysis $16.51 -0.16 (-0.96%) Closing price 04:00 PM EasternExtended Trading$16.54 +0.02 (+0.15%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFDA EventsFinancialsNews and TrendsSEC Filings About Fortress Biotech Stock (NASDAQ:FBIOP) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Fortress Biotech alerts:Sign Up Key Stats Today's Range$16.37▼$16.7050-Day Range$16.51▼$19.9452-Week Range$6.27▼$21.43Volume16,218 shsAverage Volume20,170 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield14.17%Price TargetN/AConsensus RatingN/A Company Overview Fortress Biotech, Inc. is a biopharmaceutical company focused on developing and commercializing medicines for serious diseases with significant unmet medical needs. The company uses a subsidiary-based business model in which specialized biotechnology companies advance therapies in areas including oncology, dermatology, rare diseases, infectious diseases and neurology. Fortress and its subsidiaries develop products across multiple stages, from early research and clinical development to regulatory approval and commercialization. Its portfolio has included treatments for rare and serious conditions, as well as topical and other specialty medicines. The company also works with external partners and uses its development platform to support the creation of additional biotechnology businesses and product candidates. Founded in 2014, Fortress Biotech is headquartered in the United States and primarily serves patients through the development and commercialization of therapies for domestic and international markets. Its securities include preferred stock listed on the Nasdaq Capital Market under the symbol FBIOP.AI Generated. May Contain Errors. Read More Receive FBIOP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Fortress Biotech and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. FBIOP Stock News HeadlinesFortress Biotech, Inc. - Preferred stock price target increased by 10.56% to $37.34September 15, 2026 | msn.comFortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment ConferenceSeptember 8, 2026 | globenewswire.comA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the country entirely - as concerns grow about the next phase of the AI market. One AI insider says investors should reassess their positions before September 30, pointing to a critical shift ahead for tech and AI-related stocks.September 30 at 1:00 AM | TradeSmith (Ad)Fortress Biotech Reports Second Quarter 2026 Financial Results and Recent Corporate HighlightsAugust 13, 2026 | globenewswire.comFortress Biotech Just Netted $159 Million - Its Preferred Shares Could Be The Real WinnerJuly 30, 2026 | seekingalpha.comFortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B FinancingJuly 27, 2026 | finance.yahoo.comFortress Biotech to Participate in A.G.P.'s Annual Virtual Healthcare ConferenceMay 18, 2026 | globenewswire.comFortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate HighlightsMay 14, 2026 | globenewswire.comSee More Headlines FBIOP Stock Analysis - Frequently Asked Questions How have FBIOP shares performed this year? Fortress Biotech's stock was trading at $9.49 at the start of the year. Since then, FBIOP stock has increased by 74.0% and is now trading at $16.51. How do I buy shares of Fortress Biotech? Shares of FBIOP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/30/2026Next Earnings (Estimated)11/16/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (9m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 FBIOP's financial health is in the Green zone, according to TradeSmith. FBIOP has been in this zone for over 9 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:FBIOP CIK1429260 Webwww.fortressbiotech.com Phone781-652-4500FaxN/AEmployees78Year Founded2006Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$68.47 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks That Will Be Magnificent in 2026Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NASDAQ:FBIOP) was last updated on 9/30/2026 by MarketBeat.com Staff. From Our PartnersHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredNot SpaceX. Not Tesla. Smaller.SpaceX isn't public, but its paperwork references a company trading for about 14 dollars a share. Roughly 4,40...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fortress Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fortress Biotech With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
